Case Report: Clinical Outcome and Image Response of Two Patients With Secondary High-Grade Glioma Treated With Chemoradiation, PCV, and Cannabidiol
We describe two patients with a confirmed diagnosis of high-grade gliomas (grades III/IV), both presenting with O6-methylguanine-DNA methyltransferase (MGMT) methylated and isocitrate dehydrogenase (IDH-1) mutated who, after subtotal resection, were submitted to chemoradiation and followed by PCV, a...
Main Authors: | Paula B. Dall'Stella, Marcos F. L. Docema, Marcos V. C. Maldaun, Olavo Feher, Carmen L. P. Lancellotti |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2018.00643/full |
Similar Items
-
Radiation and chemotherapy for high‐risk lower grade gliomas: Choosing between temozolomide and PCV
by: Susan G. R. McDuff, et al.
Published: (2020-01-01) -
The Impact of Timing of Concurrent Chemoradiation in Patients With High-Grade Glioma in the Era of the Stupp Protocol
by: Kwanza T. Warren, et al.
Published: (2019-03-01) -
Neutrophil–lymphocyte ratio dynamics are useful for distinguishing between recurrence and pseudoprogression in high-grade gliomas
by: Huang Y, et al.
Published: (2019-07-01) -
Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma
by: Julianna K. Bronk, et al.
Published: (2018-02-01) -
Post-treatment imaging of high-grade gliomas
by: Darshana Sanghvi
Published: (2015-04-01)